Sustained remission over 36 months of advanced hepatocellular carcinoma after short-term sorafenib therapy

Dig Dis Sci. 2013 May;58(5):1428-32. doi: 10.1007/s10620-012-2522-8. Epub 2013 Jan 10.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / administration & dosage*
  • Carcinoma, Hepatocellular / drug therapy*
  • Humans
  • Liver Neoplasms / drug therapy*
  • Male
  • Niacinamide / administration & dosage
  • Niacinamide / analogs & derivatives*
  • Phenylurea Compounds / administration & dosage*
  • Remission Induction
  • Sorafenib

Substances

  • Antineoplastic Agents
  • Phenylurea Compounds
  • Niacinamide
  • Sorafenib